DDDevang Desai

Devang Desai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Devang Desai has a total of 170 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Temporal Trends in the Management of Urethral Stricture Disease in Australia Over the 21st Century

    by Yam Ting Ho, Omattage M. Perera, Femi E. Ayeni, Nicola Jeffery, Isaac A. Thangasamy, Devang Desai

    Objective: To identify trends in the management and prevalence of urethral stricture disease in Australia over a period of two decades: Methods: Databases related to urethral procedures between financial year (FY) 2000/01 and 2022/23 were sourced from Australian Institute of Health & Welfare and Medicare Benefits Scheme. The data include length of stay and procedure counts based on age, gender and procedure type. Nationwide subsidy burden was estimated from Service Australia data. Results: Between FY2000/01 and 2022/23, there is a decreasing trend in urethral procedures performed. We observed a 9% increase in urethroplasty procedures and a 9% decrease in urethral dilatation procedures. Urethral procedures are commonly performed in 70–79 years old, though a rise in urethroplasty in younger patients over time was observed. The ratio of urethroplasty to endoscopic procedures has shifted from 1:13 to 1:5 in the last two decades. The estimated length of stay related to urethral procedures has reduced from 2.1 to 1.4 days. The nationwide subsidy burden between FY2002/03 and 2022/23 has increased from $23 113 to $26 825 per 100 000 persons. Conclusion: Within the last two decades, there is a reduction in urethral procedures performed nationwide; however, among the procedures performed, we observed a rise in urethroplasty and reduction in dilatation procedures. We observed more urethral procedures performed in older males, with a notable increased uptake in urethroplasty in younger patients. This suggests that there is a shift to more sub‐specialised reconstructive surgical techniques for the management of urethral stricture disease within Australia. Finally, the nationwide estimated subsidy burden has increased slightly.

  • Open Access

    The Influence of Prostate Volume on Magnetic Resonance Imaging Diagnostic Performance and the Adjunctive Role of Prostate‐Specific Membrane Antigen Positron Emission Tomography in Detecting Clinically Significant Prostate Cancer

    by Matthieu Bryan Chun‐Hei Mo, Sachin Joshi, William Harrison, Madeleine Bain, Nikhil Sapre, Devang Desai

    To evaluate the influence of prostate volume on the diagnostic accuracy of multiparametric MRI (mpMRI) in detecting clinically significant prostate cancer (ISUP Grade ≥ 2), using radical prostatectomy (RP) histopathology as the reference standard. A secondary objective was to assess the adjunctive value of PSMA PET in identifying clinically significant cancer in cases where mpMRI findings were negative or low suspicion, particularly in larger prostate volumes. We conducted a multicentred regional observational study totalling 167 patients who underwent mpMRI, PSMA PET, transperineal (TP) biopsy and RP between October 2022 and February 2025. The average age across the total population was 65.6 years. The median PIRADS score across all patients was 4, and the average prostate specific antigen level at the time of imaging was 7.4 ng/mL. TP prostate biopsy methods included MRI‐ultrasound Fusion Monalisa ( n = 111) and traditional cognitive fusion biopsy methods, including grid and precision point ( n = 56). Prostate volumes were stratified into three categories: ≤ 20, 21–29 and ≥ 30 cc. The average age in each volume group was 63.2 years for ≤ 20 cc, 65.7 years for 21–29 cc and 67.9 years for ≥ 30 cc. The mean prostate volume within each group was 17.4, 25.1 and 48.6 cc, respectively. MpMRI‐reported ISUP grade groups were compared against final RP histopathology with reports performed by specialist uropathologists. Discrepancies were classified as underestimation or overestimation of histopathology. Statistical comparisons were performed using chi‐squared tests with significance set at p < 0.05. For the secondary objective, patients with negative or low suspicion on mpMRI (PIRADS ≤ 2) but were found to have ISUP ≥ 2 disease on RP were identified. In these discordant cases, PSMA PET imaging was reviewed to determine whether it correctly localised the index lesion, thereby assessing its adjunctive diagnostic value, particularly in larger prostates. Multiparametric MRI grading accuracy decreased significantly with increasing prostate volume: 78% concordance in the ≤ 20 cc group, 65% in the 21–29 cc group and 52% in the ≥ 30 cc group ( p = 0.012). Underestimation of tumour grade was the predominant discrepancy, particularly in prostates ≥ 30 cc, where clinically significant disease (ISUP ≥ 2) was frequently misclassified as ISUP 1. PSMA PET identified significant lesions in several mpMRI‐negative or low‐suspicion cases, particularly in larger prostate volumes. Multiparametric MRI accuracy in detecting clinically significant prostate cancer diminishes as prostate volume increases, likely due to decreased lesion conspicuity within enlarged transition zones. This limitation supports incorporating prostate volume into risk stratification and imaging interpretation, with consideration for adjunctive diagnostics such as PSMA PET or confirmatory biopsy in larger prostate volumes.

  • Open Access

    Male stress urinary incontinence surgery in Australia: Temporal trends over two decades

    by Omattage Mahasha Perera, Yam Ting Ho, Femi E. Ayeni, Eric Chung, Vincent Tse, Devang Desai

    Objective: This study aims to evaluate the national trends in the surgical management of male stress incontinence (SUI) in the Australian population over the 21st century. Methods: Data was sourced from the Australian Institute of Health and Welfare (AIHW) national morbidity database and Medicare Benefits Schedule (MBS) statistics reports. Annual data from financial years (FY) 2000/01 to 2022/23 was collected. Male SUI procedures are grouped into slings, paraurethral bulking agents (PBA) and artificial urinary sphincters (AUS). The annual procedural counts, revisions and yearly changes were obtained. The estimated subsidy burden was reported as AUD per capita (per 100 000 persons). Results: Between FY2000/01 and 2022/23, the aggregate number of male SUI procedures (excluding revisions) increased by 272% (from 288 to 1072). This is largely driven by the increase in AUS procedures, particularly amongst men aged 70–74 years. Male sling procedures demonstrated a substantial early increase followed by plateauing in recent years, while PBA declined over the same period. Revision procedures increased by 444% (from 41 to 223), largely due to AUS revisions and replacement. Over the same period, the estimated aggregate subsidy burden has increased from $13 749 to $53 269 per capita. Conclusion: The surgical management of male SUI in Australia has been transformative over the past two decades. Trends indicate an increase in male SUI procedures, particularly AUS procedures accompanied by an increase in AUS revision and replacement. These trends reflect both expanding surgical demand and durability of continence devices, which has subsequently led to a substantial increase in estimated subsidy burden.

  • Open Access

    Clinical and diagnostic challenges of fossa navicularis stricture

    by Ashan Canagasingham, Mohamad Fairuz Bin Mohamad Sharin, Sachin Joshi, Madeleine Bain, Matthieu Bryan Chun-Hei Mo, Devang Desai

    Fossa navicularis strictures (FNS) pose unique diagnostic and reconstructive challenges due to their rhomboidal anatomy, limited vascularity, and strong association with lichen sclerosus (LS). Patients frequently experience functional disturbance, especially urinary spraying. This is a narrative review that summarizes current evidence on the clinical features, diagnostic evaluation, and management of FNS, with emphasis on anatomical constraints and reconstructive considerations. Conventional imaging often underestimates distal strictures, making clinical history and careful meatal-glans examination central to diagnosis. The native fossa geometry promotes laminar flow but is easily disrupted by reconstruction, contributing to postoperative spraying despite adequate patency. Limited distal blood supply and chronic inflammatory changes further impair healing. Endoscopic treatments show poor durability. Flap repairs may be suitable for non-LS disease, while oral mucosal grafts—buccal or lingual—offer superior outcomes in LS. Optimal management requires accurate clinical assessment and etiology-driven reconstruction. Graft-based urethroplasty remains the most durable option, particularly for LS-associated strictures, highlighting the need for specialized distal urethral expertise.

  • Open Access

    Feasibility and short-term outcomes of the dorsal inlay skin flap for challenging distal penile urethral strictures—a novel case series

    by Devang Desai, Sachin Joshi, Madeleine Bain, Mohamad Fairuz

    Distal penile +/− meatus and fossa navicularis urethral stricture disease (USD) presents major reconstructive challenges owing to poor local vascularity and a high risk of dorsal graft failure. This study describes the novel Dorsal External Skin Augmented Inlay (DESAI) flap urethroplasty, a single-stage technique designed to achieve durable patency in distal ischemic urethral strictures while preserving glans morphology and cosmesis. A prospective case series of seven men (mean age 54.7±13.9 years) with distal penile USD and impaired local vascularity underwent DESAI flap urethroplasty by a single reconstructive urologist between 2020 and 2025. Four patients (57.1%) had previous failed reconstructions and one (14.3%) had prior pelvic radiotherapy (RT). Functional outcomes were assessed using maximum urinary flow rate (Qmax), International Prostate Symptom Score (IPSS), International Index of Erectile Function-5 (IIEF-5), and disease-specific quality-of-life (QoL) measures pre- and post-operatively. Statistical significance was defined as P<0.05. Mean follow-up was 7.3±6.6 (median 4; range 3–22) months. Mean Qmax increased from 7.6±9.5 to 19.9±6.9 mL/s (P=0.002). Mean IPSS improved from 20.4±4.0 to 2.9±2.5 (P<0.001), and mean QoL scores from 3.3±1.0 to 1.1±0.6 (P<0.001). A transient early decline in IIEF-5 (20.7±6.0 to 16.0±6.3; P<0.001) was observed. All patients (100%) had successful post-operative outcome defined as Qmax ≥15 mL/s without reintervention and reported subjective improvement in voiding and cosmetic satisfaction. No fistula, dehiscence, or flap necrosis occurred. The DESAI flap urethroplasty provides a reliable, vascularised, single-stage solution for distal USD. By circumventing the need for graft neovascularisation, it achieves excellent functional recovery and patient satisfaction with minimal morbidity. Further multi-centre validation and long-term follow-up are warranted to confirm durability and broader applicability.

  • Putative Tissue‐Based Biomarkers of Male Genital Lichen Sclerosus—A Systematic Literature Review

    by D. Desai, A. Reinke, E. Stehr, E. J. Whiteside, G. De Win, L. C. E. Windus

    Male genital lichen sclerosis (mGLS) is a chronic progressive inflammatory disease with potential complications including urethral strictures and penile cancer. Despite its clinical significance, the molecular mechanisms underlying mGLS remain poorly understood, and male‐specific data are limited. This systematic review consolidates current evidence on tissue‐based gene and protein expression in mGLS, aiming to identify commonly investigated biomarkers and highlight gaps in the literature. Using the JBI Sumari interface, our research strategy identified a total of 24 studies with considerable variability in targets and methodologies. Only a small subset of 12 genes and proteins was assessed and only one gene, p16, was assessed across multiple studies, limiting the strength of conclusions. QIAGEN Ingenuity Pathway Analysis was used to explore canonical pathways and disease associations linked to reported biomarkers. While preliminary patterns suggest involvement of inflammatory and fibrotic pathways, further research is needed to validate these findings and assess their diagnostic, prognostic or therapeutic potential. This review provides a foundation for future studies focused on improving molecular understanding and clinical management of mGLS.


  • Skin flap urethroplasty: the ‘Yaxley–Orandi flap’ – honouring its history

    by Sachin Joshi, Matthieu Mo, Mohamad Fairuz, Devang Desai


  • Open Access

    Comparing laser vs mechanical lithotripsy in suction mini‐PCNL for kidney stone disease: A prospective multicentre study by the endourology section of EAU

    by Angelo Cormio, Vineet Gauhar, Bhaskar K. Somani, Jaisukh Kalathia, Nariman Gadzhiev, Marek Zawadzki, Mahmoud Laymon, Karl Tan, Gopal Ramdas Tak, Theodoros Tokas, et al.

    Objectives: To compare perioperative outcomes, complications and stone‐free rates (SFRs) between laser and non‐laser lithotripsy in suction‐assisted mini‐PCNL (SM‐PCNL). Subjects and Methods: This prospective multicentre study enrolled adults with normal kidneys undergoing SM‐PCNL (14–22 Fr) across 30 international centres (March–November 2024). Patients were divided into laser (Group 1) and non‐laser (Group 2) groups. Propensity score matching (2:1) was performed based on age, sex, Guy's score and patient position. Primary outcomes were complications and 30‐day SFR assessed by CT. Multivariable logistic regression identified predictors of complete stone clearance and complications. Results: After matching, 748 patients were analysed (Group 1: 448; Group 2: 300). Non‐laser devices were associated with shorter lithotripsy (12 vs 18 min, p < 0.001) and operative times (37 vs 45 min, p < 0.001) and higher SFR (intraoperative: 91.3% vs 80.7%; 30‐day: 87.7% vs 82.1%). However, transfusions (3.3% vs 0.2%), pelvic perforation and pleural injury (each 3.0%) were more common in Group 2. On multivariable analysis, single‐step dilation (OR 3.05) and sheath sizes of 16.5–18 Fr (OR 1.98) or 20–22 Fr (OR 2.72) were associated with higher odds of stone‐free status, while skin‐to‐stone distance >8 cm (OR 0.5) and combined fluoroscopy/ultrasound access (0.28) reduced this likelihood. Stone volume (OR 1.03), serial dilation with non‐metal dilators (OR 2.64) and combined fluoroscopy/ultrasound access (OR 2.11) were factors associated with higher odds of complications. The lithotripsy technology had no direct bearing on complications. Conclusions: Both laser and non‐laser lithotripsy are effective in SM‐PCNL. Non‐laser devices improve efficiency and lasers were preferentially used with 14–18 fr access tracts.


  • Donor site morbidity and impact on oral health following buccal mucosal graft harvesting for urethroplasty: a prospective study

    by Devang Desai, Sachin Joshi, Kapilan Ravichandran, Hannah Flynn, Stefan De Wachter, Gunter De Win

    Purpose To evaluate patient-reported oral health and pain and buccal donor site complications in adults who underwent BMG harvesting utilizing two validated questionnaires. Materials and methods An ethics-approved prospective observational study was conducted among a cohort of 40 adults who had a BMG urethroplasty between June 2020 and October 2021. All cases were performed by one fellowship-trained genitourinary reconstructive surgeon. Oral health was appraised before and after BMG harvesting via the validated Oral Impacts of Daily Performance (OIDP) questionnaire. Post-operative pain at the BMG donor site was assessed by administering the Visual Analogue Scale for pain (VAS) both pre-and post-operatively. Statistical analysis was undertaken to identify risk factors for increased post-operative pain and decreased oral health. Results The cohort included sub-meatal, penile, bulbar, and pan-urethral strictures. Most cases (36/40) were a primary urethroplasty, but 4 cases were a re-do urethroplasty. Only 5 participants (12.5%) experienced complication(s) at the donor site such as bleeding (2/40, 5%), infection (1/40, 2.5%), hyper granulation tissue (1/40, 2.5%), and long-term difficulty with mouth opening (3/40, 7.5%). Most participants (32/40, 80%) had at least one daily oral performance affected by BMG harvesting. Eating, speaking, and cleaning teeth were the most impacted domains. However, there was no statistically significant decrease in oral health at either 3- or 6 months post-BMG harvesting (p < 0.05). Almost all participants (38/40, 95%) reported no pain at the donor site before BMG harvesting. Pain at the donor site peaked at 1 week post-operatively (28/40, 70%), but the majority were pain-free by 3 months post-BMG harvesting (35/40, 87.5%). Conclusion BMG harvesting is an effective means of procuring a suitable graft for urethroplasty. Whilst pain at the donor site is experienced in the immediate post-operative period, long-term pain is a rare complication. Overall oral health is not detrimentally impacted by BMG harvesting.


  • Open Access

    Female urethral stricture: A multi‐centre experience and lessons learnt

    by Madeleine Bain, Daniel Esteban Gomez Zapata, Kapilan Ravichandran, Cora Fogaing, Apurva Anand, Amey Talpallikar, Shreyas Bhadranawar, Sanjay Kulkarni, Devang Desai, Pankaj Joshi

    Objectives: To review demographics, surgical techniques and outcomes of female patients undergoing buccal mucosal graft substitution urethroplasty.Materials and methods: An international multi‐institutional study was performed through a retrospective review of a prospectively managed database of female urethroplasty outcomes at two sites from December 2016 to June 2023. Institutions included a high‐volume tertiary referral centre performing 500 urethroplasties annually, and a regional centre with a fellowship‐trained urethroplasty surgeon performing ~50 urethroplasties annually. Female urethroplasty accounted for 2% of urethroplasties performed, utilising dorsal onlay, ventral inlay and double‐face techniques.Results: Forty‐two patients underwent female urethroplasty between 2016 and 2023; 20 dorsal onlay grafts, 14 ventral inlay grafts and 8 double‐face urethroplasty. The mean age was 45 years (SD 12.07) and mean follow‐up 27 months (SD 17.22). The most common aetiology was idiopathic in 59%. The most common presenting symptom was obstructive lower urinary tract symptoms in 86%. Urethral dilatations were the most common treatment before urethroplasty, with a mean of 9 (SD 1.2) dilations pre‐urethroplasty. Stricture locations seen were; proximal 7%, proximal to mid‐14%, mid‐31%, mid to distal 10% and distal 38%. A total of 88% were successful overall; dorsal onlay was 100%, ventral inlay urethroplasties 71% and double‐face 88%. Mean Qmax improvement was 291% at 6 months. In those who required dilatations or further surgery postoperatively (n = 5); four were ventral inlay (one mid‐distal, three distal), and one double‐face distal stricture. All patients including those requiring secondary treatments were continent and did not require intermittent self‐catheterisation or suprapubic catheter insertion.Conclusion: Urethroplasty is an effective long‐term therapeutic option for managing female urethral strictures. Dorsal onlay urethroplasty demonstrated the highest success rate, and stands out as a versatile technique, addressing distal to proximal urethral strictures. However, the chosen urethroplasty technique should be tailored to the characteristics of the stricture, patient and surgeons experience.